Table 1.
Comparison with patients’ characteristicsbetween BA.1/2 period and BA.5 period in2022.
| | | Jan-Mar (n=135, BA.1) | Jul-Sep (n=160, BA.4/5) | p value | | Age | 66.5+-16.0 | | 68.7+-19.0 | | 0.14 | | Antibiotics (+) | 14.8%(20/135) | | 26.3% (42/160) | | 0.016* | | | Respiratory | | 10.4%(14/135) | 16.9% (27/160) | 0.14 | | | Urinary | | 1.5%(2/135) | | 0.6%(1/160) | 0.47 | | | Abdomen | | 1.5%(2/135) | | 5.0%(8/160) | 0.09 | | | Skin | | 0.7%(1/135) | | 1.9%(3/160) | 0.4 | | | Brain | | 0 | | 1.3%(2/160) | 0.19 | | | Bacteremia | | 0.7%(1/135) | | 0 | 0.28 | | | Unknown | | 0 | | 0.6%(1/160) | 0.36 | | Total Mortality | 7.9%(10/135) | | 1.7% (2/160) | | 0.008** |
|
|